News
On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym: RC18; brand name: ??�) in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback